In a first of its kind comparative study, Mindpeak's CE-marked HER2 AI for breast cancer diagnosis was compared to three other commercial AIs (e.g. Visiopharm). Mindpeak's AI showed the highest accuracy of all AIs in terms of balanced clinical scores (88.1%) for HER2-low, higher than the score of the next best AI (67.3%) and higher than the concordance of pathologists with the reference score (85.5%). Furthermore, Mindpeak's AI received the highest scores in a usability evaluation of the AI softwares in all categories. This study was conducted by Cypath-RB together with Institut Gustave Roussy and was presented at the world's leading annual meeting for pathology, the USCAP 2023 (United States and Canadian Academy of Pathology), in New Orleans in mid-March.
Mindpeak's HER2 low comes out on top in comparative study by Cypath
Related reading
No items found.
Elevate Your Diagnostic Workflow with Clinical-Grade AI
Whether you are looking to scale your lab’s capacity with our existing high-performance IHC suites or require a custom AI solution tailored to your specific diagnostic workflow, Mindpeak is your dedicated partner in precision pathology.
Our technology is already trusted in over 40 labs globally and features the most comprehensive integration ecosystem in the industry, with 18+ clinical IMS partner integrations to ensure a "plug-and-play" experience with your existing hardware. Stop manual reader variability and start delivering reproducible, algorithm-driven results for every patient
Join the future of digital pathology with our diagnostic AI platform.
